000 | 01924 a2200589 4500 | ||
---|---|---|---|
005 | 20250516092104.0 | ||
264 | 0 | _c20130131 | |
008 | 201301s 0 0 eng d | ||
022 | _a1756-0500 | ||
024 | 7 |
_a10.1186/1756-0500-5-225 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAbebe, Gemeda | |
245 | 0 | 0 |
_aRelatively low primary drug resistant tuberculosis in southwestern Ethiopia. _h[electronic resource] |
260 |
_bBMC research notes _cMay 2012 |
||
300 |
_a225 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntitubercular Agents _xtherapeutic use |
650 | 0 | 4 | _aCoinfection |
650 | 0 | 4 | _aCross-Sectional Studies |
650 | 0 | 4 | _aDrug Resistance, Multiple, Bacterial |
650 | 0 | 4 |
_aEthambutol _xtherapeutic use |
650 | 0 | 4 |
_aEthiopia _xepidemiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHIV Infections _xepidemiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIsoniazid _xtherapeutic use |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
650 | 0 | 4 | _aOdds Ratio |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 |
_aRifampin _xtherapeutic use |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aSputum _xmicrobiology |
650 | 0 | 4 |
_aStreptomycin _xtherapeutic use |
650 | 0 | 4 |
_aTuberculosis, Multidrug-Resistant _xdiagnosis |
650 | 0 | 4 |
_aTuberculosis, Pulmonary _xdiagnosis |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aAbdissa, Ketema | |
700 | 1 | _aAbdissa, Alemseged | |
700 | 1 | _aApers, Ludwig | |
700 | 1 | _aAgonafir, Mulualem | |
700 | 1 | _ade-Jong, Bouke C | |
700 | 1 | _aColebunders, Robert | |
773 | 0 |
_tBMC research notes _gvol. 5 _gp. 225 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/1756-0500-5-225 _zAvailable from publisher's website |
999 |
_c21770652 _d21770652 |